Impedance methods for investigation of cerebral circulation.
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D001932:Brain Neoplasms / Q000503:physiopathology; D002245:Carbon Dioxide / Q000494:pharmacology; D002340:Carotid Artery Diseases / Q000503:physiopathology; D002543:Cerebral Hemorrhage / Q000503:physiopathology; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000503:physiopathology; D006259:Craniocerebral Trauma / Q000503:physiopathology; D004569:Electroencephalography; D004827:Epilepsy / Q000503:physiopathology; D004877:Ergoloid Mesylates / Q000494:pharmacology; D006408:Hematoma, Subdural / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000503:physiopathology; D006985:Hyperventilation; D002537:Intracranial Arteriosclerosis / Q000503:physiopathology; D008722:Methods; D008881:Migraine Disorders / Q000503:physiopathology; D009539:Nicotinic Acids / Q000494:pharmacology; D005996:Nitroglycerin / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D010300:Parkinson Disease / Q000503:physiopathology; D010992:Plethysmography, Impedance; D011187:Posture; D012039:Regional Blood Flow; D014655:Vascular Resistance; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D009539:Nicotinic Acids; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D002245:Carbon Dioxide; D004877:Ergoloid Mesylates; D000255:Adenosine Triphosphate; D010208:Papaverine; D005996:Nitroglycerin